Tarsons Products (NSE:TARSONS) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:TARSONS Tarsons Products Ltd NSE:TARSONS
82 GF Score
Price ₹266.60
GF Value ₹567.89
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tarsons Products Research & Development?

Tarsons Products NSE:TARSONS +0.58% 82 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:TARSONS with a GF Score™ of 82/100 and a GF Value™ of ₹567.89 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tarsons Products's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Tarsons Products  (NSE:TARSONS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tarsons Products Research & Development Related Terms

Tarsons Products Research & Development Historical Data

* Premium members only.

The historical data trend for Tarsons Products's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsons Products Research & Development Chart

Tarsons Products Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Tarsons Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:TARSONS
82GF Score
Tarsons Products Ltd NSE:TARSONS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tarsons Products Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Tarsons Products (NSE:TARSONS) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Tarsons Products and its competitors.
Is Tarsons Products' Research & Development too high?
Tarsons Products' current Research & Development is ₹0 Mil. Overall, Tarsons Products has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' Research & Development compare to ISRG and BDX?
Tarsons Products' Research & Development of ₹0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tarsons Products and its competitors. Tarsons Products's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹567.89, compared to a current price of ₹266.60 — trading 53.1% below its estimated fair value. The current Research & Development is ₹0 Mil. Tarsons Products' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?

Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued. The current stock price of ₹266.60 is trading 53.1% below its estimated GF Value™ of ₹567.89. GuruFocus considers Tarsons Products to be Significantly Undervalued.

Key valuation signals for NSE:TARSONS:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹567.89 vs. price of ₹266.60 (53.1% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tarsons Products Business Description

Other Exchanges 543399:India
Address Martin Burn Buisness Park, Room No. 902, BP- 3, Salt Lake, Sector-V, Kolkata, WB, IND, 700091
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
82GF Score

Get the complete analysis for NSE:TARSONS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹266.60
Price
₹567.89
GF Value